Morgan Stanley Neuro Sense Therapeutics Ltd. Call Options Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRSN
# of Institutions
14Shares Held
647KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il254KShares$276,8560.0% of portfolio
-
Jane Street Group, LLC New York, NY64.6KShares$70,4530.0% of portfolio
-
Hrt Financial LP New York, NY64.4KShares$70,1850.0% of portfolio
-
Xtx Topco LTD London, X041.9KShares$45,6670.0% of portfolio
-
Meitav Dash Investments LTD40KShares$43,6000.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $12.7M